Skip to search formSkip to main contentSkip to account menu

Neuroleptic Malignant Syndrome

Known as: neuroleptic malignant, malignant neuroleptic, Neuroleptic Malignant Syndromes 
A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
The authors review the literature on persistent sequelae of neuroleptic malignant syndrome (NMS). They highlight the clinical… 
Review
1994
Review
1994
Between October 1981 and September 1989, 564 patients admitted to the Department of Psychiatry of the Hospital of Oita Medical… 
Highly Cited
1991
Highly Cited
1991
Neuroleptic malignant syndrome (NMS), a rare but serious side effect of psychotropic drugs, is usually attributed to blockade of… 
Review
1991
Review
1991
NMS is a rare and idiosyncratic reaction that occurs with the use of dopamine antagonists or the withdrawal of dopamine agonists… 
Review
1987
Review
1987
The neuroleptic malignant syndrome (NMS) is an evidently underdiagnosed but potentially lethal consequence of treatment with… 
Highly Cited
1985
Highly Cited
1985
A generalmethodfor the synthesesof no-carrier-added(NCA)18F-labeled butyrophenone neuroleptics—benperidol, haloperidol… 
Highly Cited
1983
Highly Cited
1983
It is well established that neuroleptic drugs are antagonists of brain dopamine receptors. The role of the reported increase in… 
Highly Cited
1973
Highly Cited
1973
THE NEUROLEPTIC drugs (major tranquilizers) selectively antagonize a number of behavioral and physiological actions of dopamine…